Defect in SNAREs prevents the surface expression of CRT [200] and RNA interference targeting SNARE-based exocytosis resulted in reduced capacity of cancer cells incubated with anthracyclines, oxaliplatin, or UVC light to induce protective immunity in vivo. This evidence concerns the gene CALR and cancer.